|
NDUFB5 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.02380000033264E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.65089999951229E-07 |
| Normal-vs-Stage2 |
8.473800E-01 |
| Normal-vs-Stage3 |
1.56010000029738E-07 |
| Normal-vs-Stage4 |
3.75089959092634E-10 |
| Stage1-vs-Stage2 |
9.679500E-03 |
| Stage1-vs-Stage3 |
2.405200E-01 |
| Stage1-vs-Stage4 |
9.524000E-03 |
| Stage2-vs-Stage3 |
2.637900E-03 |
| Stage2-vs-Stage4 |
1.364670E-04 |
| Stage3-vs-Stage4 |
1.007010E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.27820004264856E-09 |
| Normal-vs-AfricanAmerican |
7.763700E-03 |
| Normal-vs-Asian |
1.378260E-04 |
| Caucasian-vs-AfricanAmerican |
2.720400E-01 |
| Caucasian-vs-Asian |
7.527600E-01 |
| AfricanAmerican-vs-Asian |
5.107600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.45909999996297E-06 |
| Normal-vs-Female |
2.55470000043445E-07 |
| Male-vs-Female |
8.080600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.6572999996305E-07 |
| Normal-vs-Age(41-60Yrs) |
2.87579999813659E-08 |
| Normal-vs-Age(61-80Yrs) |
2.072000E-02 |
| Normal-vs-Age(81-100Yrs) |
4.896400E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.409600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.516100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.091400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.339600E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.862600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.060200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.394400E-01 |
| Classical-VS-Follicular |
1.81470000026884E-07 |
| Classical-VS-Other |
9.135600E-01 |
| Classical-VS-Normal |
3.34919869615646E-11 |
| Tall-VS-Follicular |
5.81180000014392E-07 |
| Tall-VS-Other |
6.970600E-01 |
| Tall-VS-Normal |
3.12960000137252E-08 |
| Follicular-VS-Other |
1.345180E-01 |
| Follicular-VS-Normal |
8.919600E-01 |
| Other-VS-Normal |
1.578430E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.017000E-04 |
| Normal-vs-N1 |
2.1611046285841E-11 |
| N0-vs-N1 |
4.74260000005167E-06 |
|
|
